Scarica l'app Stockscreener
4.07
0.49%
-0.02
Pre-mercato:
4.07
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.09
Aprire:
$4.04
Volume 24 ore:
54,640
Relative Volume:
0.29
Capitalizzazione di mercato:
$29.51M
Reddito:
-
Utile/perdita netta:
$-29.96M
Rapporto P/E:
-0.1473
EPS:
-27.6253
Flusso di cassa netto:
$-31.64M
1 W Prestazione:
+0.25%
1M Prestazione:
-0.73%
6M Prestazione:
-60.18%
1 anno Prestazione:
+5.44%
Intervallo 1D:
$3.96
$4.0897
Intervallo di 1 settimana:
$3.955
$4.25
Portata 52W:
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Nome
Briacell Therapeutics Corp
Settore
Industria
Telefono
(604) 921-1810
Indirizzo
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
4.07 | 29.51M | 0 | -29.96M | -31.64M | -27.63 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-02-14 | Iniziato | H.C. Wainwright | Buy |
Briacell Therapeutics Corp Borsa (BCTX) Ultime notizie
MSN Money - MSN
BriaCell Announces Six Clinical Data Presentations at ASCO 2026 - The Manila Times
Six metastatic breast cancer studies put BriaCell on ASCO's 2026 agenda - Stock Titan
BriaCell to implement 1-for-10 reverse stock split to maintain Nasdaq listing - MSN
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit - MSN
BriaCell (BCTXL) Q4 Outlook Earnings ReportHigh Volatility - Cổng thông tin điện tử tỉnh Lào Cai
BCTX (BriaCell Therapeutics Corp.) posts narrower than expected Q1 2026 loss, shares rise 1.76% today.Hot Community Stocks - Cổng thông tin điện tử Tỉnh Sơn La
BCTXZ (BriaCell) outlines late-stage oncology pipeline progress as key focus in latest quarterly earnings release.Crowd Consensus Signals - Cổng thông tin điện tử tỉnh Tây Ninh
BriaCell Shares Slide 22% After Announcing Dilutive Public Offering - MSN
BriaCell Therapeutics : Investor Presentation (2026Apr21 Investor Presentation) - marketscreener.com
Stocks in play: BriaCell Therapeutics Corp. - Barchart.com
BriaCell Therapeutics Corp. - Baystreet.ca
BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting - GuruFocus
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models - The Manila Times
BriaCell presents phase 3 breast cancer quality of life data at AACR - Investing.com India
BriaCell Therapeutics : Investor Presentation (2026Apr20 Investor Presentation) - marketscreener.com
BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting - GuruFocus
BriaCell presents phase 3 breast cancer quality of life data at AACR By Investing.com - Investing.com South Africa
What should I do with BriaCell (BCTX) stock today (Pressure Mounts) 2026-04-20Retail Trader Ideas - Cổng thông tin điện tử tỉnh Lào Cai
BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting - Investing News Network
Late-stage breast cancer patients preserved quality of life in trial - Stock Titan
BriaCell: Advancing Toward Approval with Late-Stage Breast Cancer Immunotherapy - The Globe and Mail
Certain Performance Share Units of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 15-APR-2026. - marketscreener.com
Certain Options of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 15-APR-2026. - marketscreener.com
Certain Warrants of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 15-APR-2026. - marketscreener.com
BriaCell Therapeutics Corp. (BCTXW) - Minichart
BriaCell Stock Dips After-Hours On Pricing $13.8M Public Offering, But Retail's Busy Cheering Clinical Milestone - MSN
What is happening with BriaCell (BCTX) Stock right now | BCTX Q4 Earnings: Beats Estimates by $2.31Financial Update - UBND thành phố Hải Phòng
Growth Report: Does BriaCell Therapeutics Corp align with a passive investing strategy2026 Action & Growth Oriented Trade Recommendations - baoquankhu1.vn
Sectors Review: Is BriaCell Therapeutics Corp Equity Warrant stock a hidden gem2026 Key Lessons & Risk Managed Investment Signals - baoquankhu1.vn
Briacell Therap (NASDAQ:BCTX) Cut to “Strong Sell” at Wall Street Zen - Defense World
Is BriaCell (BCTXL) Stock Leading the Market | Price at $1.06, Up 2.40%Open Stock Signal Network - Cổng thông tin điện tử Tỉnh Sơn La
Quarterly Earnings: How does BriaCell Therapeutics Corp Equity Warrant compare to its peers2026 Volatility Report & Capital Protection Trading Alerts - baoquankhu1.vn
Is BriaCell (BCTX) Stock Worth Holding | Price at $4.47, Up 1.02%Income Investing - Cổng thông tin điện tử Tỉnh Sơn La
Why Is BriaCell Therapeutics Corp. (BCTX) Stock Down Today? - Meyka
Is BriaCell (BCTX) Stock Priced Correctly | Price at $4.32, Up 5.37%Retail Trader Ideas - UBND thành phố Hải Phòng
BCTX Pulls Back: Market Rotation Hits Healthcare - Cổng thông tin điện tử tỉnh Tây Ninh
Briacell Therapeutics Corp Azioni (BCTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):